BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 12479561)

  • 1. Seroprevalence of rubella among women of childbearing age in Taiwan after nationwide vaccination.
    Su SB; Guo HR
    Am J Trop Med Hyg; 2002 Nov; 67(5):549-53. PubMed ID: 12479561
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Seroepidemiology study of rubella antibodies among pregnant women from seven Asian countries: evaluation of the rubella vaccination program in Taiwan.
    Tseng HF; Chang CK; Tan HF; Yang SE; Chang HW
    Vaccine; 2006 Jul; 24(29-30):5772-7. PubMed ID: 16759764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Rubella seroprevalence in Tunisian childbearing women two years after vaccination program introduction].
    Chaabouni M; Messadi F; Fki L; M Z; Hammami A; Karray H
    Pathol Biol (Paris); 2012 Jun; 60(3):170-3. PubMed ID: 22578467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of a vaccination programme on the distribution of rubella antibodies in women of childbearing age.
    Hambling MH
    Lancet; 1975 May; 1(7916):1130-3. PubMed ID: 49484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Seroprevalence of rubella among Jordanian women of childbearing age.
    Jarour N; Hayajneh WA; Balbeesi A; Otoom H; Al-Shurman A; Kharabsheh S
    Vaccine; 2007 May; 25(18):3615-8. PubMed ID: 17280747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Susceptibility of pregnant women to rubella and the implications of immunization programs].
    Villalbí JR; Graells C; Marín T
    An Esp Pediatr; 1988 Feb; 28(2):137-40. PubMed ID: 3355032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rubella seroepidemiology and estimations of the catch-up immunisation rate and persistence of antibody titers in pregnant women in Taiwan.
    Lin CC; Yang CY; Shih YL; Hsu HW; Yang TH; Cheng YW; Chang CF; Hsieh LC; Chen BH; Lee CH; Huang YL
    BJOG; 2011 May; 118(6):706-12. PubMed ID: 21385304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rubella seroprevalence among women of childbearing age residing in a rural region: is there a need for rubella vaccination in Turkey?
    Aksakal FN; Maral I; Cirak MY; Aygun R
    Jpn J Infect Dis; 2007 Jul; 60(4):157-60. PubMed ID: 17642522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinguishing between primary infection and reinfection with rubella vaccine virus by IgG avidity assay in pregnant women.
    Hamkar R; Jalilvand S; Abdolbaghi MH; Jelyani KN; Esteghamati A; Hagh-goo A; Mohktari-Azad T; Nategh R
    East Mediterr Health J; 2009; 15(1):94-103. PubMed ID: 19469431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of a rubella prevention policy on the outcome of rubella in pregnancy.
    Edmond E; Zealley H
    Br J Obstet Gynaecol; 1986 Jun; 93(6):563-7. PubMed ID: 3730325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccination in secondary school students expedites rubella control and prevents congenital rubella syndrome.
    He H; Yan R; Tang X; Zhou Y; Deng X; Xie S
    BMC Infect Dis; 2016 Nov; 16(1):723. PubMed ID: 27899091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a rubella vaccination strategy: contribution of a rubella susceptibility study of women of childbearing age in Kyrgyzstan, 2001.
    Malakmadze N; Zimmerman LA; Uzicanin A; Shteinke L; Caceres VM; Kasymbekova K; Sozina I; Glasser JW; Joldubaeva M; Aidyralieva C; Icenogle JP; Strebel PM; Reef SE
    Clin Infect Dis; 2004 Jun; 38(12):1780-3. PubMed ID: 15227627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Seroprevalence of rubella antibodies and determinants of susceptibility to rubella in a cohort of pregnant women in Canada, 2008-2011.
    Gilbert NL; Rotondo J; Shapiro J; Sherrard L; Fraser WD; Ward BJ
    Vaccine; 2017 May; 35(23):3050-3055. PubMed ID: 28461066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Seroepidemiologic study of rubella in childbearing women in Aragon, Spain (2003-2007)].
    Hernández Díaz R; Rodrigo Val MP; Misiego Peral A; Roc Alfaro ML; Adiego Sancho MB
    Gac Sanit; 2011; 25(1):20-2. PubMed ID: 21074904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Seroprevalence of rubella among women of childbearing age in Switzerland.
    Zufferey J; Jacquier P; Chappuis S; Spinnler O; Hohlfeld P; Zuber PL; Bille J
    Eur J Clin Microbiol Infect Dis; 1995 Aug; 14(8):691-6. PubMed ID: 8565987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunity to rubella in women of childbearing age in the United Kingdom.
    Noah ND; Fowle SE
    BMJ; 1988 Nov; 297(6659):1301-4. PubMed ID: 3144367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening and immunization of rubella-susceptible women. Experience in a large, prepaid medical group.
    Shlian DM
    JAMA; 1978 Aug; 240(7):662-3. PubMed ID: 671687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rubella seroepidemiology among Korean women: Two decades after a combined vaccination strategy.
    Choe SA; Choe YJ; Paek JY
    Int J Infect Dis; 2020 May; 94():25-28. PubMed ID: 32112963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The results of an investigation on the prevalence rate of rubella antibody, history of rubella infection and of vaccination in pregnant women].
    Hirosawa H; Nakamura Y; Watanabe N; Yoneyama K; Date R
    Kansenshogaku Zasshi; 1988 Jul; 62(7):652-6. PubMed ID: 3141526
    [No Abstract]   [Full Text] [Related]  

  • 20. Seroepidemiology of rubella in northern Greece.
    Gioula G; Diza-Mataftsi E; Alexiou-Daniel S; Kyriazopoulou-Dalaina V
    Eur J Clin Microbiol Infect Dis; 2004 Aug; 23(8):631-3. PubMed ID: 15243817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.